Upregulation of gelatinases and epithelial-mesenchymal transition in small airway remodeling associated with chronic exposure to wood smoke

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zou, Yimin ^a   Li, Shaoxing ^a   Zou, Weifeng ^b   Hu, Guoping ^b   Zhou, Yumin ^a   Peng, Gongyong ^a   He, Fang ^b   Li, Bing ^b   Ran, Pixin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UVOMORULIN; VIMENTIN; GELATINASE; SMOKE; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

AIR; AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MODEL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LONG TERM EXPOSURE; LUNG PARENCHYMA; MORPHOMETRICS; NONHUMAN; PASSIVE SMOKING; PROTEIN EXPRESSION; RAT; RESPIRATORY EPITHELIUM; SMOKE; SPRAGUE DAWLEY RAT; TRACHEA; UPREGULATION; WESTERN BLOTTING; WOOD; ADVERSE EFFECTS; ANIMAL; BLOOD; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENVIRONMENTAL EXPOSURE; EPITHELIUM; EPITHELIUM CELL; LUNG; METABOLISM; PATHOLOGY; TOBACCO;

AIRWAY REMODELING; ANIMALS; CELLS, CULTURED; ENVIRONMENTAL EXPOSURE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FEMALE; GELATINASES; LUNG; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; SMOKE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOBACCO; UP-REGULATION; WOOD;

EID: 84900563502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096708     Document Type: Article

References (41)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347-365.
2. Sethi JM, Rochester CL (2000) Smoking and chronic obstructive pulmonary disease. Clin Chest Med 21: 67-86, viii. (Pubitemid 30183773)
3. Liu S, Zhou Y, Wang X, Wang D, Lu J, et al. (2007) Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax 62: 889-897. (Pubitemid 47598354)
4. Rivera RM, Cosio MG, Ghezzo H, Salazar M, Perez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 12: 972-977.
5. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350: 2645-2653. (Pubitemid 38787999)
6. Wright J (1995) Emphysema: concepts under change - a pathologist's perspective. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 8: 873-880.
7. Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, et al. (2009) Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem 16: 1214-1228.
8. Mehra D, Geraghty PM, Hardigan AA, Foronjy R (2012) A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PloS one 7: e52889.
9. Chen Y, Chen P, Hanaoka M, Droma Y, Kubo K (2008) Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13: 1014-1021.
10. Brajer B, Batura-Gabryel H, Nowicka A, Kuznar-Kaminska B, Szczepanik A (2008) Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol 59: 145-152.
11. Lagente V, Boichot E (2010) Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol 48: 440-444.
12. Beeh K, Beier J, Kornmann O, Buhl R (2003) Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respiratory medicine 97: 634-639. (Pubitemid 36675664)
13. Bergeron C, Tulic M, Hamid Q (2007) Tools used to measure airway remodelling in research. European Respiratory Journal 29: 596-604. (Pubitemid 46372110)
14. Togo S, Holz O, Liu X, Sugiura H, Kamio K, et al. (2008) Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 178: 248.
15. Borthwick LA, Parker SM, Brougham KA, Johnson GE, Gorowiec MR, et al. (2009) Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax 64: 770-777.
16. Sukhwinder S, David R, Amir S, Chris W, Konrad MH, et al. (2011) Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 12.
17. Milara J, Peiró T, Serrano A, Cortijo J (2013) Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 68: 410-420.
18. Ramos C, Cisneros J, Gonzalez-Avila G, Becerril C, Ruiz V, et al. (2009) Increase of matrix metalloproteinases in woodsmoke-induced lung emphysema in guinea pigs. Inhalation toxicology 21: 119-132.
19. Hanaoka M, Droma Y, Chen Y, Agatsuma T, Kitaguchi Y, et al. (2011) Carbocisteine protects against emphysema induced by cigarette smoke extract in rats. CHEST Journal 139: 1101-1108.
20. Bracke K, D'hulst A, Maes T, Demedts I, Moerloose K, et al. (2007) Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clinical & Experimental Allergy 37: 1467-1479.
21. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, et al. (2004) Immunostimulatory DNA inhibits transforming growth factor-b expression and airway remodeling. Am J Respir Cell Mol Biol 30: 651-661. (Pubitemid 38591216)
22. Selman M, Cisneros-Lira J, Gaxiola M, Ramírez R, Kudlacz EM, et al. (2003) Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. CHEST Journal 123: 1633-1641. (Pubitemid 36549786)
23. Kohan M, Breuer R, Berkman N (2009) Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 41: 290-296.
24. Deng Y, Yang Z, Gao Y, Xu H, Zheng B, et al. (2013) Toll-Like Receptor 4 Mediates Acute Lung Injury Induced by High Mobility Group Box-1. PloS one 8: e64375.
25. Ning W, Dong Y, Sun J, Li C, Matthay MA, et al. (2007) Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. American journal of respiratory cell and molecular biology 36: 480.
26. Montano M, Beccerril C, Ruiz V, Ramos C, Sansores RH, et al. (2004) Matrix metalloproteinases activity in COPD associated with wood smoke. CHEST Journal 125: 466-472. (Pubitemid 38223625)
27. Dix-Cooper L, Eskenazi B, Romero C, Balmes J, Smith KR (2012) Neurodevelopmental performance among school age children in rural Guatemala is associated with prenatal and postnatal exposure to carbon monoxide, a marker for exposure to woodsmoke. Neurotoxicology 33: 246-254.
28. Mishra V (2003) Indoor air pollution from biomass combustion and acute respiratory illness in preschool age children in Zimbabwe. International Journal of Epidemiology 32: 847-853.
29. Rivera R, Cosio M, Ghezzo H, Salazar M, Pérez-Padilla R (2008) Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. The International Journal of Tuberculosis and Lung Disease 12: 972-977.
30. Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, et al. (2007) Woodsmoke health effects: a review. Inhal Toxicol 19: 67-106. (Pubitemid 44863605)
31. Regalado J, Pérez-Padilla R, Sansores R, Paramo Ramirez JI, Brauer M, et al. (2006) The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care Med 174: 901-905. (Pubitemid 44564790)
32. Dolhnikoff M, da Silva LF, de Araujo BB, Gomes HA, Fernezlian S, et al. (2009) The outer wall of small airways is a major site of remodeling in fatal asthma. Journal of Allergy and Clinical Immunology 123: 1090-1097. e1091.
33. YL L, Sugar S (2002) Proteinases in chronic obstructive pulmonary disease. Biochemical Society Transactions 30.
34. Chakrabarti S, Patel KD (2005) Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 31: 599-621. (Pubitemid 40967244)
35. Perng DW, Chang KT, Su KC, Wu YC, Chen CS, et al. (2011) Matrix metalloprotease-9 induces transforming growth factor-beta(1) production in airway epithelium via activation of epidermal growth factor receptors. Life Sci 89: 204-212.
36. Gueders MM, Foidart J-M, Noel A, Cataldo DD (2006) Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. European journal of pharmacology 533: 133-144. (Pubitemid 43340010)
37. Daheshia M (2005) Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD). Current Medical Research and Opinion 21: 587-593.
38. Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annual Review of Pathological Mechanical Disease 4: 435-459.
39. Scotton CJ, Chambers RC (2007) Molecular Targets in Pulmonary FibrosisThe Myofibroblast in Focus. CHEST Journal 132: 1311-1321. (Pubitemid 47621009)
40. Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, et al. (2010) Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 11: 105.
41. Sohal SS, Reid D, Soltani A, Ward C, Weston S, et al. (2010) Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 15: 930-938.